These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29988125)

  • 21. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relevance of beta-cell function for improved glycemic control after gastric bypass surgery.
    Blanco J; Jiménez A; Casamitjana R; Flores L; Lacy A; Conget I; Vidal J
    Surg Obes Relat Dis; 2014; 10(1):9-13; quiz 189-90. PubMed ID: 24342036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes.
    Schneider M; Lerch M; Papiri M; Buechel P; Boehlen L; Shaw S; Risen W; Weidmann P
    J Hypertens; 1996 May; 14(5):669-77. PubMed ID: 8762212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?
    Popovic DS; Stokic E; Popovic SL
    Curr Pharm Des; 2015; 21(36):5292-8. PubMed ID: 26438316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential of incretin-based therapies in type 1 diabetes.
    Suen CS; Burn P
    Drug Discov Today; 2012 Jan; 17(1-2):89-95. PubMed ID: 21920456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
    White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
    Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ghrelin mitigates β-cell mass loss during insulitis in an animal model of autoimmune diabetes mellitus, the BioBreeding/Worcester rat.
    Baena-Nieto G; Lomas-Romero IM; Mateos RM; Leal-Cosme N; Perez-Arana G; Aguilar-Diosdado M; Segundo C; Lechuga-Sancho AM
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27103341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unraveling Verapamil's Multidimensional Role in Diabetes Therapy: From β-Cell Regeneration to Cholecystokinin Induction in Zebrafish and MIN6 Cell-Line Models.
    Arefanian H; Al Madhoun A; Al-Rashed F; Alzaid F; Bahman F; Nizam R; Alhusayan M; John S; Jacob S; Williams MR; Abukhalaf N; Shenouda S; Joseph S; AlSaeed H; Kochumon S; Mohammad A; Koti L; Sindhu S; Abu-Farha M; Abubaker J; Thanaraj TA; Ahmad R; Al-Mulla F
    Cells; 2024 May; 13(11):. PubMed ID: 38891081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of beta-cell dysfunction in early type 1 diabetes.
    Sims EK; Mirmira RG; Evans-Molina C
    Curr Opin Endocrinol Diabetes Obes; 2020 Aug; 27(4):215-224. PubMed ID: 32618633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rise and fall of insulin secretion in type 1 diabetes mellitus.
    Tsai EB; Sherry NA; Palmer JP; Herold KC
    Diabetologia; 2006 Feb; 49(2):261-70. PubMed ID: 16404554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substance P preserves pancreatic β-cells in type 1 and type 2 diabetic mice.
    Um J; Jung N; Kim D; Choi S; Lee SH; Son Y; Park KS
    Biochem Biophys Res Commun; 2018 May; 499(4):960-966. PubMed ID: 29626466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI).
    Pitocco D; Crinò A; Di Stasio E; Manfrini S; Guglielmi C; Spera S; Anguissola GB; Visalli N; Suraci C; Matteoli MC; Patera IP; Cavallo MG; Bizzarri C; Pozzilli P;
    Diabet Med; 2006 Aug; 23(8):920-3. PubMed ID: 16911633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of gamma aminobutyric acid (GABA) or GABA with glutamic acid decarboxylase (GAD) on the progression of type 1 diabetes mellitus in children: Trial design and methodology.
    Choat HM; Martin A; Mick GJ; Heath KE; Tse HM; McGwin G; McCormick KL
    Contemp Clin Trials; 2019 Jul; 82():93-100. PubMed ID: 31229619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Verapamil chronicles: advances from cardiovascular to pancreatic β-cell protection.
    Arefanian H; Koti L; Sindhu S; Ahmad R; Al Madhoun A; Al-Mulla F
    Front Pharmacol; 2023; 14():1322148. PubMed ID: 38089047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 Diabetes.
    Cheng ST; Chen L; Li SY; Mayoux E; Leung PS
    PLoS One; 2016; 11(1):e0147391. PubMed ID: 26807719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention versus intervention of type 1 diabetes.
    Brooks-Worrell B; Palmer JP
    Clin Immunol; 2013 Dec; 149(3):332-8. PubMed ID: 23803322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis for residual islet β-cell secretion function in young patients with newly diagnosed type 1 diabetes.
    Miao H; Zhang J; Gu B; Gao A; Hong J; Zhang Y; Gu W
    J Diabetes; 2019 Oct; 11(10):818-825. PubMed ID: 30848017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.
    Dejgaard TF; Knop FK; Tarnow L; Frandsen CS; Hansen TS; Almdal T; Holst JJ; Madsbad S; Andersen HU
    BMJ Open; 2015 Apr; 5(4):e007791. PubMed ID: 25838513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.